1.Gut microbiota derived metabolites in cardiovascular health and disease.
Protein & Cell 2018;9(5):416-431
Trillions of microbes inhabit the human gut, not only providing nutrients and energy to the host from the ingested food, but also producing metabolic bioactive signaling molecules to maintain health and elicit disease, such as cardiovascular disease (CVD). CVD is the leading cause of mortality worldwide. In this review, we presented gut microbiota derived metabolites involved in cardiovascular health and disease, including trimethylamine-N-oxide (TMAO), uremic toxins, short chain fatty acids (SCFAs), phytoestrogens, anthocyanins, bile acids and lipopolysaccharide. These gut microbiota derived metabolites play critical roles in maintaining a healthy cardiovascular function, and if dysregulated, potentially causally linked to CVD. A better understanding of the function and dynamics of gut microbiota derived metabolites holds great promise toward mechanistic predicative CVD biomarker discoveries and precise interventions.
Cardiovascular Diseases
;
metabolism
;
microbiology
;
pathology
;
Gastrointestinal Microbiome
;
Humans
;
Metabolome
2.Roles of Enteric Microbial Composition and Metabolism in Health and Diseases.
The Korean Journal of Gastroenterology 2013;62(4):191-205
A complex microbiota colonizes mucosal layers in different regions of the human gut. In the healthy state, the microbial communities provide nutrients and energy to the host via fermentation of non-digestible dietary components in the large intestine. In contrast, they can play roles in inflammation and infection, including gastrointestinal diseases and metabolic syndrome such as obesity. However, because of the complexity of the microbial community, the functional connections between the enteric microbiota and metabolism are less well understood. Nevertheless, major progress has been made in defining dominant bacterial species, community profiles, and systemic characteristics that produce stable microbiota beneficial to health, and in identifying their roles in enteric metabolism. Through studies in both mice and humans, we are recently in a better position to understand what effect the enteric microbiota has on the metabolism by improving energy yield from food and modulating dietary components. Achieving better knowledge of this information may provide insights into new possibilities that reconstitution of enteric microbiota via diet can provide the maintenance of healthy state and therapeutic/preventive strategies against metabolic syndrome such as obesity. This review focuses on enteric microbial composition and metabolism on healthy and diseased states.
Animals
;
Bacteria/growth & development/metabolism
;
Diet
;
Gastrointestinal Diseases/*microbiology/pathology
;
Humans
;
Inflammation/microbiology/pathology
;
Intestines/microbiology
;
Metabolic Syndrome X/*microbiology/pathology
;
*Microbiota
;
Probiotics
3.A Case of Gastric Candidiasis Presented as Subepithelial Mass in an Immunocompromised Host.
Su Hyun KIM ; Sang Gyun KIM ; Seung Joo KANG ; Mi Na KIM ; Jin Myung PARK ; Hyun Jin JO ; Moon Sun CHOI ; In Sung SONG
The Korean Journal of Gastroenterology 2009;53(1):43-47
Hepatosplenic candidiasis is also called chronic disseminated candidiasis and usually seen in patients with hematologic malignancies who have just recovered from an episode of neutropenia. Gastric candidiasis most commonly present as a mucosal lesion such as an ulcer or erosions, but other gastric lesion is very rare. We experienced a case of gastric candidiasis which presented as gastric subepithelial mass in a 60-year old woman who had undergone the 2nd consolidation chemotherapy due to acute myeloid leukemia. The pathologic diagnosis was confirmed by fine needle aspiration of the gastric subepithelial mass under the guidance of endoscopic ultrasonography.
Candidiasis/*diagnosis/immunology
;
Endoscopy, Gastrointestinal
;
Female
;
Humans
;
*Immunocompromised Host
;
Middle Aged
;
Stomach Diseases/microbiology/*pathology/ultrasonography
;
Tomography, X-Ray Computed
4.The use of a second biopsy from the gastric body for the detection of Helicobacter pylori using rapid urease test.
Andrew WONG ; Siok Siong CHING ; Ai Sha LONG
Singapore medical journal 2014;55(12):644-647
INTRODUCTIONThe use of an additional biopsy from the gastric body may help improve the detection of Helicobacter pylori during endoscopy. This study aimed to determine whether such an additional biopsy is necessary in routine rapid urease test (RUT), and whether acid suppression and antibiotic therapy affect RUT results.
METHODSPatients recruited had two gastric mucosal biopsies taken - one from the gastric antrum and the other from the gastric body. Each biopsy was placed into separate RUT kits. Information on previous or current use of proton-pump inhibitors, H2 receptor antagonist, bismuth and antibiotics was obtained. Patients on any of those drugs one week prior to endoscopy were considered to have a positive drug history (PDH).
RESULTSOf the 400 patients recruited, 311 had negative RUTs and 89 had at least one positive RUT. Between the PDH and negative drug history (NDH) groups, there was a significant difference in the distribution of the location of the biopsies that yielded positive RUTs (p = 0.023). The NDH group had a higher proportion of patients who had positive RUTs for both locations, whereas the PDH group had a higher proportion of patients who had positive RUTs for only one location.
CONCLUSIONAs RUT results are significantly affected by the use of acid suppression and antibiotic therapies, biopsies for RUT should be taken from both the gastric antrum and body to minimise false negative results.
Adult ; Aged ; Antacids ; pharmacology ; Anti-Bacterial Agents ; pharmacology ; Endoscopy ; Endoscopy, Gastrointestinal ; Female ; Gastric Mucosa ; microbiology ; pathology ; Gastrointestinal Diseases ; diagnosis ; epidemiology ; microbiology ; Helicobacter Infections ; diagnosis ; Helicobacter pylori ; drug effects ; isolation & purification ; History, Ancient ; Humans ; Middle Aged ; Singapore ; epidemiology ; Urease ; analysis
5.The role of gut microbiota in the gut-brain axis: current challenges and perspectives.
Xiao CHEN ; Roshan D'SOUZA ; Seong-Tshool HONG
Protein & Cell 2013;4(6):403-414
Brain and the gastrointestinal (GI) tract are intimately connected to form a bidirectional neurohumoral communication system. The communication between gut and brain, knows as the gut-brain axis, is so well established that the functional status of gut is always related to the condition of brain. The researches on the gut-brain axis were traditionally focused on the psychological status affecting the function of the GI tract. However, recent evidences showed that gut microbiota communicates with the brain via the gut-brain axis to modulate brain development and behavioral phenotypes. These recent findings on the new role of gut microbiota in the gut-brain axis implicate that gut microbiota could associate with brain functions as well as neurological diseases via the gut-brain axis. To elucidate the role of gut microbiota in the gut-brain axis, precise identification of the composition of microbes constituting gut microbiota is an essential step. However, identification of microbes constituting gut microbiota has been the main technological challenge currently due to massive amount of intestinal microbes and the difficulties in culture of gut microbes. Current methods for identification of microbes constituting gut microbiota are dependent on omics analysis methods by using advanced high tech equipment. Here, we review the association of gut microbiota with the gut-brain axis, including the pros and cons of the current high throughput methods for identification of microbes constituting gut microbiota to elucidate the role of gut microbiota in the gut-brain axis.
Brain
;
metabolism
;
Central Nervous System
;
metabolism
;
Gastrointestinal Tract
;
metabolism
;
microbiology
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Liver
;
metabolism
;
Metabolic Diseases
;
metabolism
;
pathology
;
Metagenome
;
Receptors, G-Protein-Coupled
;
metabolism
6.Structural shifts of gut flora in rat acute alcoholic liver injury and jianpi huoxue decoction's effect displayed by ERIC-PCR fingerprint.
Yang CHENG ; Hai-hui WANG ; Yi-yang HU ; Gao-feng CHEN ; Jian PING ; Jing-hua PENG ; Qin FENG
Chinese journal of integrative medicine 2011;17(5):361-368
OBJECTIVETo study the structural shifts of gut flora in rats with acute alcoholic liver injury (AALI), and the effect of jianpi huoxue decoction (JPHXD) on the gut flora.
METHODSThirty-six Sprague-Dawley rats were randomly allocated to the control, AALI and JPHXD groups equally. The rats in the control group were given water and those in AALI and JPHXD groups were given ethanol by intragastric gavage for 5 days, while rats in the JPHXD group were administered JPHXD simultaneously. The blood and liver tissue were collected at the end of the experiment. The activities of serum alkaline aminotransferase (ALT), aspartate aminotransferase (AST), hepatic γ-glutamyltranspetidase (γ-GT) and hepatic triglyceride (TG) levels were determined. Plasma endotoxin level in the portal vein was measured. Pathological changes of liver tissues were determined by hematoxylin and eosin (HE) staining and oil red O staining. The total DNA of gut flora were extracted from fecal samples by Bead-beating method and determined by ERIC-PCR fingerprint method. The similarity cluster analysis and principal component analysis were performed to analyze the ERIC-PCR fingerprint respectively.
RESULTSIn the AALI group, the ratio of liver/body weight, activities of ALT, AST and hepatic γ-GT, amount of hepatic TG were elevated significantly compared with those in the control group (all P<0.01). JPHXD decreased the ratio, activities of ALT, AST, γ-GT and TG significantly compared with those in the AALI group (P<0.05 or P<0.01). HE and oil red O staining showed that fat deposited markedly in liver tissue, while JPHXD alleviated pathological changes markedly. Plasma LPS level in rat portal vein in the AALI group increased significantly (P<0.01), but it was decreased significantly in the JPHXD group (P<0.01). The cluster analysis and principal component analysis of ERIC-PCR fingerprint showed that gut flora in the AALI group changed markedly, and JPHXD could recover gut flora to some extent.
CONCLUSIONSThe structure of gut flora shifted markedly during acute alcoholic liver injury, JPHXD had prevention effect through the modification of gut flora.
Animals ; Azo Compounds ; metabolism ; Bacteria ; genetics ; Body Weight ; Cluster Analysis ; Consensus Sequence ; genetics ; DNA Fingerprinting ; methods ; DNA, Intergenic ; genetics ; Drugs, Chinese Herbal ; therapeutic use ; Freezing ; Gastrointestinal Tract ; microbiology ; pathology ; Liver ; microbiology ; pathology ; Liver Diseases, Alcoholic ; drug therapy ; microbiology ; pathology ; Organ Size ; Phylogeny ; Polymerase Chain Reaction ; methods ; Principal Component Analysis ; Rats ; Rats, Sprague-Dawley ; Repetitive Sequences, Nucleic Acid ; genetics ; Staining and Labeling
7.Relationship between the types of Helicobacter pylori strains and chronic upper gastrointestinal diseases in children.
Bo CHU ; Li-Rong JIANG ; Sha ZHOU ; Ya-Zhen XU ; Min-Zhi YIN
Chinese Journal of Contemporary Pediatrics 2007;9(3):201-204
OBJECTIVETo study the relationship of the types of Helicobacter pylori (H. pylori) strains with the classification and the severity of chronic gastro-duodenal diseases in children.
METHODSOne hundred and fifteen children with chronic upper gastrointestinal symptoms who were diagnosed as H. pylori infection by gastroscopy were enrolled in this study. H. pylori strains were serotyped by immunoblot technique. The gastric biopsy specimens of all patients were studied histologically.
RESULTSType I H. pylori strains were confirmed in 84 cases (73.0%), intermediate type strains in 21 cases (18.3%), and type II strains in 10 cases (8.7%). Type I H. pylori strains infection caused a moderate gastric mucosal inflammation in 83 cases and a severe inflammation in 1 case. Intermediate type H. pylori strains infection caused a moderate gastric mucosal inflammation in 21 cases. Type II H. pylori strains infection caused a mild gastric mucosal inflammation in 2 cases and a moderate inflammation in 8 cases. Different types of H. pylori strains resulted in different severity of gastric mucosal inflammation (x2=15.444, P < 0.01). The gastric mucosal inflammation due to type I H. pylori strains was the most severe, while the inflammation due to type II H. pylori strains was relatively mild. The incidence of nodulus lymphaticus of gastric mucosa due to type I, type II and intermediate type H. pylori strains infection was 76.2%, 47.6% and 40.0%, respectively (x2=10.171, P < 0.01). The classification of chronic gastro-duodenal diseases was not associated with the types of H. pylori strains.
CONCLUSIONSType I strains were the leading cause of H. pylori infection in children. All of types of H. pylori strains can cause pathohistologic changes of gastric mucosa. Type I H. pylori strains infection can result in the most severe gastric mucosal inflammation and the highest incidence of nodulus lymphaticus. The immunoblot serotyping of H.pylori strains may be useless for the classification of chronic upper gastrointestinal diseases but it is helpful for the evaluation of the severity of the diseases in children.
Adolescent ; Antibodies, Bacterial ; blood ; Antigens, Bacterial ; genetics ; Bacterial Proteins ; genetics ; Child ; Child, Preschool ; Chronic Disease ; Female ; Gastric Mucosa ; pathology ; Gastrointestinal Diseases ; microbiology ; pathology ; Helicobacter Infections ; complications ; diagnosis ; Helicobacter pylori ; classification ; Humans ; Male
8.Prognostic Significance of Infection Acquisition Sites in Spontaneous Bacterial Peritonitis: Nosocomial versus Community Acquired.
Joon Young SONG ; Seong Ju JUNG ; Cheong Won PARK ; Jang Wook SOHN ; Woo Joo KIM ; Min Ja KIM ; Hee Jin CHEONG
Journal of Korean Medical Science 2006;21(4):666-671
Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection as a complication of end stage liver disease. The outcome is related to the severity of hepatorenal function, gastrointestinal bleeding, and many others; however it is not well known whether the infection acquisition sites have an effect on the prognosis of SBP. In order to identify the prognostic significance of the acquisition sites, we studied 106 patients who were diagnosed as culture positive SBP between October 1998 and August 2003. Thirty-two episodes were nosocomial and 74 were community acquired. Gramnegative bacilli such as Escherichia coli were dominant in both of the nosocomial and community-acquired SBPs. Despite significantly higher resistance to cefotaxime in nosocomial isolates compared to community-acquired isolates (77.8% vs. 13.6%, p=0.001), no difference was found regarding short or long term prognosis. Infection acquisition sites were not related to short or long term prognosis either. Shock, gastrointestinal bleeding and renal dysfunction were related to short term prognosis. Only Child-Pugh class C was identified as an independent prognostic factor of long-term survival.
Time Factors
;
Survival Rate
;
Shock/etiology/mortality
;
Prognosis
;
Peritonitis/complications/microbiology/*pathology
;
Multivariate Analysis
;
Middle Aged
;
Male
;
Klebsiella pneumoniae/drug effects/growth & development
;
Kidney Diseases/etiology/mortality
;
Humans
;
Gastrointestinal Hemorrhage/etiology/mortality
;
Female
;
Escherichia coli/drug effects/growth & development
;
Drug Resistance, Bacterial
;
Cross Infection/complications/microbiology/pathology
;
Community-Acquired Infections/complications/microbiology/pathology
;
Ciprofloxacin/pharmacology
;
Cefotaxime/pharmacology
;
Bacterial Infections/complications/microbiology/*pathology
;
Anti-Bacterial Agents/pharmacology
;
Aged
9.Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.
Na Ri LEE ; Ji Won JANG ; Hee Sun KIM ; Ho Young YHIM
The Korean Journal of Internal Medicine 2015;30(4):550-553
No abstract available.
Adult
;
Antineoplastic Agents/*adverse effects
;
Antitubercular Agents/therapeutic use
;
Biopsy
;
Female
;
Gastrointestinal Stromal Tumors/*drug therapy/pathology/surgery
;
Humans
;
Imatinib Mesylate/*adverse effects
;
Lung Diseases, Interstitial/*chemically induced/diagnosis
;
Mycobacterium tuberculosis/*isolation & purification
;
Protein Kinase Inhibitors/*adverse effects
;
Rectal Neoplasms/*drug therapy/pathology/surgery
;
Tomography, X-Ray Computed
;
Tuberculosis, Pulmonary/diagnosis/drug therapy/*microbiology